 |
| Welcome to the AstraZeneca Settlement Website There is a Class Action Settlement with AstraZeneca Pharmaceuticals LP (“AstraZeneca”), the maker of Zoladex®, a drug used in the treatment of prostate cancer, advanced breast cancer, endometriosis and fibrosis. This lawsuit is not about the safety of Zoladex®. The name of the lawsuit is In re: Pharmaceutical Industry Average Wholesale Price Litigation, Docket No. 01-CV-12257-PBS, MDL No. 1456. The lawsuit claims that Medicare Part B Beneficiaries paid more than they should have for Zoladex®. The lawsuit claims the pricing information reported by AstraZeneca for Zoladex® was false and inflated. The pricing information is called the “average wholesale price” (“AWP”). AWPs were used to set the amount Medicare reimburses for drugs and the co-payment Medicare Part B Beneficiaries pay. AstraZeneca denies any wrongdoing. AstraZeneca has agreed to pay up to $24 million to Medicare Part B Beneficiaries who a) paid a percentage co-payment for Zoladex® based on AWP, and b) submit a valid Claim Form. You are a member of the Class if you made a percentage co-payment under Medicare Part B for Zoladex® from January 1, 1991 through December 31, 2004. Heirs and legal representatives are included. IF YOU RESIDE IN ALABAMA, ALASKA, GEORGIA, IOWA, KENTUCKY, LOUISIANA, MISSISSIPPI, MONTANA, OR VIRGINIA, PLEASE CLICK HERE TO DOWLOAD A COPY OF THE FULL NOTICE WHICH WILL EXPLAIN, IN DETAIL, YOUR RIGHTS AND OPTIONS
Update: The settlement has been preliminarily approved. * PLEASE NOTE: The Deadline for Filing Claims has passed. If you would like to file a claim, you are still urged to do so. However it is up to the Court’s discretion to permit payment of claims received after the Deadline for Filing Claims. * PLEASE NOTE: Exclusions may no longer be filed because the deadline has passed.
|